(Q45077359)

9 December 2017

title

Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack (English)

1 reference

9 December 2017

Dariusz W Kowalczyk

1

1 reference

9 December 2017

Anthony P Wlazlo

2

1 reference

9 December 2017

Wynetta Giles-Davis

3

1 reference

9 December 2017

Andreas R Kammer

4

1 reference

9 December 2017

Sunil Mukhopadhyay

5

1 reference

9 December 2017

Hildegund C J Ertl

6

1 reference

9 December 2017

publication date

1 December 2003

1 reference

9 December 2017

1 reference

9 December 2017

volume

10

1 reference

9 December 2017

issue

12

1 reference

9 December 2017

page(s)

870-878

1 reference

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Human tumor antigens for cancer vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

A method that allows easy characterization of tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

7 January 2021

IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

7 January 2021

A Role for the Interferon-Inducible Protein 10 in Inhibition of Angiogenesis by Interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

7 January 2021

Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700653

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700653

1 reference

Dimensions Publication ID

9 December 2017

1029074192

0 references

1 reference